Survival outcomes after toxicity-related dose modification of 5-fluorouracil, leucovorin and oxalipatin (FOLFOX) in stage III, resected colorectal cancer patients

被引：0
|
作者：
Ha, F. J. [1 ]
Aksakal, G. [1 ]
Chong, G. [1 ]
机构：
[1] Austin Hosp, Dept Med Oncol, Olivia Newton John Canc Res Inst, Melbourne, Vic, Australia
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
210P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer
    Schippinger, W.
    Samonigg, H.
    Schaberl-Moser, R.
    Greil, R.
    Thoedtmann, R.
    Tschmelitsch, J.
    Jagoditsch, M.
    Steger, G. G.
    Jakesz, R.
    Herbst, F.
    Hofbauer, F.
    Rabl, H.
    Wohlmuth, P.
    Gnant, M.
    Thaler, J.
    BRITISH JOURNAL OF CANCER, 2007, 97 (08) : 1021 - 1027
  • [32] Effect of intra-operative chemotherapy with 5-fluorouracil and leucovorin on the survival of patients with colorectal cancer after radical surgery: a retrospective cohort study
    Hu, Xuhua
    Zheng, Zhaoxu
    Han, Jing
    Li, Baokun
    Guo, Ganlin
    Guo, Peiyuan
    Yang, Yang
    Li, Daojuan
    Yan, Yiwei
    Niu, Wenbo
    Zhou, Chaoxi
    Meng, Zesong
    Feng, Jun
    Yu, Bin
    Liu, Qian
    Wang, Guiying
    CHINESE MEDICAL JOURNAL, 2023, 136 (07) : 830 - 839
  • [33] Effect of intra-operative chemotherapy with 5-fluorouracil and leucovorin on the survival of patients with colorectal cancer after radical surgery: a retrospective cohort study
    Hu Xuhua
    Zheng Zhaoxu
    Han Jing
    Li Baokun
    Guo Ganlin
    Guo Peiyuan
    Yang Yang
    Li Daojuan
    Yan Yiwei
    Niu Wenbo
    Zhou Chaoxi
    Meng Zesong
    Feng Jun
    Yu Bin
    Liu Qian
    Wang Guiying
    中华医学杂志英文版, 2023, 136 (07)
  • [34] Adjuvant chemotherapy with oxaliplatin/5-fluorouracil/leucovorin (FOLFOX) versus 5-fluorouracil/leucovorin (FL) in patients with locally advanced rectal cancer after preoperative chemoradiotherapy followed by surgery: A randomized phase II study (The ADORE)
    Hong, Yong Sang
    Nam, Byung-Ho
    Jung, Kyung Hae
    Lee, Jae-Lyun
    Kim, Kyu-Pyo
    Park, Young Suk
    Park, Joon Oh
    Kim, Sun Young
    Kim, Tae-You
    Kim, Jee Hyun
    Ahn, Joong Bae
    Kim, Tae Won
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] A phase I study of vorinostat (suberoylanilide hydroxamic acid) in combination with 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX) in patients with advanced colorectal cancer (CRC)
    Fakih, M. G.
    Pendyala, L.
    Smith, P.
    Creaven, P.
    Toth, K.
    Zwiebel, J.
    Frankel, S.
    Litwin, A.
    Huffman, L.
    Egorin, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study
    Christos Emmanouilides
    Georgia Sfakiotaki
    Nikolaos Androulakis
    Kostas Kalbakis
    Charalambos Christophylakis
    Antonia Kalykaki
    Lambros Vamvakas
    Athanasios Kotsakis
    Sofia Agelaki
    Eleni Diamandidou
    Nikolaos Touroutoglou
    Adam Chatzidakis
    Vassilis Georgoulias
    Dimitris Mavroudis
    John Souglakos
    BMC Cancer, 7
  • [37] A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen
    Cecchin, E.
    D'Andrea, M.
    Lonardi, S.
    Zanusso, C.
    Pella, N.
    Errante, D.
    De Mattia, E.
    Polesel, J.
    Innocenti, F.
    Toffoli, G.
    PHARMACOGENOMICS JOURNAL, 2013, 13 (05): : 403 - 409
  • [38] Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study
    Emmanouilides, Christos
    Sfakiotaki, Georgia
    Androulakis, Nikolaos
    Kalbakis, Kostas
    Christophylakis, Charalambos
    Kalykaki, Antonia
    Vamvakas, Lambros
    Kotsakis, Athanasios
    Agelaki, Sofia
    Diamandidou, Eleni
    Touroutoglou, Nikolaos
    Chatzidakis, Adam
    Georgoulias, Vassilis
    Mavroudis, Dimitris
    Souglakos, John
    BMC CANCER, 2007, 7 (1)
  • [39] Multicentre phase II study of bifractionated CPT-11 with bimonthly leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer pretreated with FOLFOX
    F Recchia
    G Saggio
    A Nuzzo
    A Lalli
    L Di Lullo
    A Cesta
    S Rea
    British Journal of Cancer, 2004, 91 : 1442 - 1446
  • [40] Multicentre phase II study of bifractionated CPT-11 with bimonthly leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer pretreated with FOLFOX
    Recchia, F
    Saggio, G
    Nuzzo, A
    Lalli, A
    Di Lullo, L
    Cesta, A
    Rea, S
    BRITISH JOURNAL OF CANCER, 2004, 91 (08) : 1442 - 1446
12345